Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bacterial Infection: early-phase trial registry
2 of 9 indexed Bacterial Infection trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 2 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Bacterial Infection: 9 US clinical trials tracked, 2 recruiting.
Bacterial Infection is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 3 of these trials.
Enrollment posture brief
Registry condition bacterial-infection
OPEN 2 | RECR 22% | LATE 2 | EARLY 5 | RANK #1916 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acne (22% recruiting · 27 trials)
Bacterial Infection lists 2 open slots (22% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bacterial Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bacterial Infection is recruiting below its size-band peers.
2 of 9 indexed trials (22.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Bacterial Infection research.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 3 of 9 trials (33.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Bacterial Infection enrolment sits around 54 participants.
Median target enrolment is 54 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.
-
Bacterial Infection research is mostly interventional.
8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
National Institute of Allergy and Infectious Diseases (NIAID)
NCT06709521
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Bausch Health Americas
NCT07285785
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
Cellceutix Corporation
NCT02052388
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
Forest Laboratories
NCT00633152
Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy
University of California, Irvine
NCT00915213
A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03978091
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm
North Florida Foundation for Research and Education
NCT02294175
Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
Microbion Corporation
NCT02436876
Safety of Intravenous Apramycin in Adults
National Institute of Allergy and Infectious Diseases (NIAID)
NCT05590728
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Bacterial Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bacterial Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bacterial Infection page
9 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Bacterial Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Bacterial Infection trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bacterial Infection condition card totals 9 registered trials; most-linked intervention MBN-101; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.